Lanean...

Oncological benefits of portal vein embolization for patients with hepatocellular carcinoma

Portal vein embolization (PVE) for hepatocellular carcinoma (HCC) was first introduced in 1986 and has been continuously developed throughout the years. Basically, PVE has been applied to expand the indication of liver resection for HCC patients of insufficient future liver remnant. Importantly, PVE...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ann Gastroenterol Surg
Egile Nagusiak: Beppu, Toru, Yamamura, Kensuke, Okabe, Hirohisa, Imai, Katsunori, Hayashi, Hiromitsu
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2020
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8164464/
https://ncbi.nlm.nih.gov/pubmed/34095718
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ags3.12414
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!